What theyre saying: While the new generation of incretin therapies have been revolutionary for patients living with obesity, bimagrumab addresses a critical unmet need as a therapeutic that targets fat loss while building muscle mass. Versanis CEO Mark Pruzanski The solo act The drug: Altimmunes pemvidutide is a combination GLP-1 agonist and glucagon agonist
They help curb appetite, slow gastric emptying, and reduce postprandial glucose spikes. Youve likely encountered names such as semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda). Early versions of these drugs required daily injection
Staying away from these foods can help break through a plateau during weight loss
Employer Options So, what can employers do if they want their workers to continue to receive or begin to experience the benefits of GLP-1 drugs as part of a weight-loss program without another diagnosis
Research consistently shows that discontinuing the medication leads to weight regain in most patients
